Freeze-Dried Matrices Based on Polyanion Polymers for Chlorhexidine Local Release in the Buccal and Vaginal Cavities.
Adhesiveness
Administration, Buccal
Administration, Intravaginal
Animals
Anti-Infective Agents
/ chemistry
Chlorhexidine
/ chemistry
Drug Delivery Systems
/ methods
Drug Liberation
Female
Freeze Drying
/ methods
Hyaluronic Acid
/ chemistry
Mouth Mucosa
/ metabolism
Polyelectrolytes
Polymers
/ chemistry
Swine
Vagina
/ metabolism
drug-excipient interaction(s)
hydrogel(s)
lyophilization
mucoadhesive
mucosal drug delivery
polymeric drug delivery system(s)
solid dosage form(s)
Journal
Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
12
11
2018
revised:
04
02
2019
accepted:
27
02
2019
pubmed:
12
3
2019
medline:
28
7
2020
entrez:
12
3
2019
Statut:
ppublish
Résumé
Chlorhexidine (CLX) is a wide spectrum cationic antimicrobial used for prevention and treatment of infections of buccal and vaginal cavities. To increase the residence time of CLX-based formulations at the application site and consequently reduce the daily dose frequency, new formulations composed of mucoadhesive polymers should be designed. The objective of this work was the development of matrices based on polyanionic polymers, such as sodium alginate, carboxymethylcellulose, xanthan gum and sodium hyaluronate, aimed to prolong the local release of CLX into the buccal or vaginal cavity. Matrices were prepared by freeze-drying and comply with 2 different preparative methods and characterized in terms of resistance to compression, water uptake ability, mucoadhesion, in vitro drug release behavior and antimicrobial activity toward representative pathogens of buccal and vaginal cavities. Results showed that the selection of suitable polymers associated to the adequate preparative method allowed to modulate matrix ability to hydrate, adhere to the mucosa and release the drug as well as to exert antimicrobial activity. In particular, matrix based on sodium hyaluronate was found to be the best performing formulation and could represent a versatile system for local release of CLX with potential application in both buccal and vaginal cavities.
Identifiants
pubmed: 30853513
pii: S0022-3549(19)30144-3
doi: 10.1016/j.xphs.2019.02.026
pii:
doi:
Substances chimiques
Anti-Infective Agents
0
Polyelectrolytes
0
Polymers
0
polyanions
0
Hyaluronic Acid
9004-61-9
Chlorhexidine
R4KO0DY52L
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2447-2457Informations de copyright
Copyright © 2019 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.